Introduction
The availability of annotated genome sequences of several organisms has led to a fundamental change in the way biochemical systems are analysed. Based on this reductionist information, the metabolic networks of several organisms have been reconstructed [1, 2] . The imposition of constraints on a reconstructed biochemical network leads to the definition of achievable cellular functions. Several computational methods have been developed to study the characteristics and capabilities of microorganisms using constraint-based methods. Flux Balance Analysis (FBA) is one such constraint-based method, for the analysis of biochemical systems [3, 4] . Minimisation of Metabolic Adjustment (MoMA) is a similar method, that is based on quadratic programming [5] . FBA and MoMA have been extensively used for the analysis of microbial models for various applications, from metabolic engineering [6] to drug target identification [7] . In this paper, we describe PathwayAnalyser, which is a tool for performing FBA and MoMA on reconstructed biochemical networks.
FBA involves carrying out a steady state analysis, using the stoichiometric matrix for the system in question. The system is assumed to be optimised with respect to functions such as maximisation of biomass production or minimisation of nutrient utilisation, following which it is solved to obtain a steady state flux distribution. This flux distribution is then used to interpret the metabolic capabilities of the system. The dynamic mass balance of the metabolic system is described using the stoichiometric matrix, relating the flux rates of enzymatic reactions, v nx1 to time derivatives of metabolite concentrations, x mx1 as dx/dt = S·v = 0 (at steady state) Therefore, the required flux distribution belongs to the null space of S. Since m (metabolites) < n (reactions), the system of equations is under-determined. To obtain a single solution, further biological constraints are imposed on the system, followed by the specification of a biologically relevant objective function for optimisation. Typically, the system is assumed to be optimised with respect to metabolic functions such as biomass production (max) or nutrient utilisation (min), following which it is solved to obtain a steady state flux distribution. This flux distribution is then used to interpret the metabolic capabilities of the system. The problem now is one of linear programming:
where c represents the objective function composition, in terms of the fluxes. Further, we can constrain the internal fluxes to be strictly positive and the external fluxes to be unbounded. Other constraints may also be added on the basis of the knowledge of cellular physiology.
Results and Discussion
We illustrate the capabilities of PathwayAnalyser with the example of two pathway models in M. tuberculosis. PathwayAnalyser can be used to perform FBA/MoMA on these models and subsequently analyse gene essentiality. In all cases, the deletions were not found to be lethal, since most of the metabolites have an alternate route of production.
Model

Mycolic Acid Pathway
This is based on the model published in [7] . The figure indicates a schematic of the mycolic acid pathway in M. tuberculosis.
* PathwayAnalyser performs FBA and MoMA based on the objective function for optimisation and other constraints on the system * Produces a gene deletion report detailing gene essentiality * Also outputs the flux distribution for the wild type and the in silico deletion mutants. * It is an easy-to-use command-line tool for the analysis of reconstructed metabolic networks. where I is an identity matrix of size n × n, n being the length of the vector v d . An important feature of MoMA is that the wild-type flux distribution used need not be obtained by performing an FBA; an experimentally determined flux distribution could serve better. Thus, objective functions for optimisation, which at times may not reflect the physiological situation very accurately, can be circumvented using MoMA.
Pathway Analyser
